• Profile

Comparing outcomes for patients with clinical T1b renal cell carcinoma treated with either percutaneous microwave ablation or surgery

Urology Oct 07, 2019

Shapiro DD, Wells SA, Best SL, et al. - Comprehensive clinical and pathologic data were obtained for individuals with non-metastatic renal cell carcinoma (RCC) with cT1b tumors after microwave ablation (MW), partial nephrectomy (PN) or radical nephrectomy (RN) from 2000-2018 in order to contrast perioperative and oncologic outcomes for individuals with clinical T1b RCC subsequent to treatment with MW, PN, or RN. A total of 325 individuals (40 MW, 74 PN, and 211 RN) were recognized. Patients treated with MW vs surgical individuals were elderly with greater Charlson comorbidity indices. In contrast with surgical individuals, the median length of hospitalization was shorter for MW. Two individuals relapsed following MW and had undergone repeat ablation without the following recurrence. Among MW, PN or RN, no variation in 5-yr metastasis-free survival or cancer-specific survival was discovered. Four MW individuals had a high-grade complication. Only former abdominal surgery prognosticated high-grade complications. Hence, in select comorbid individuals with clinical T1b RCC, microwave ablation was found out to be a feasible option for surgery.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen